Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,605 | 244,662 | 8,457 | 1,317 | N/A |
| Marketable Securities | 103,374 | N/A | N/A | N/A | N/A |
| TOTAL | $202,116 | $247,971 | $8,570 | $1,381 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 416 | 11 | 1 | 3 | N/A |
| Investments And Advances | 13,817 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,098 | 2,947 | 43 | 43 | 0 |
| TOTAL | $20,331 | $2,958 | $44 | $46 | $N/A |
| Total Assets | $222,447 | $250,929 | $8,614 | $1,427 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,973 | 1,002 | 1,132 | 285 | 0 |
| Accrued Expenses | 5,414 | 2,678 | 463 | 330 | N/A |
| TOTAL | $11,130 | $3,680 | $1,595 | $615 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,702 | 815 | 0 | 3,362 | 0 |
| TOTAL | $3,702 | $815 | $N/A | $3,362 | $N/A |
| Total Liabilities | $14,832 | $4,495 | $1,595 | $3,977 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,561 | 38,703 | N/A | N/A | N/A |
| Common Shares | 4 | 4 | N/A | N/A | N/A |
| Retained earnings | -112,186 | -61,578 | -34,270 | -10,220 | N/A |
| Other shareholders' equity | -386 | 0 | 41,289 | 6,857 | 0 |
| TOTAL | $207,615 | $246,434 | $7,019 | $-2,550 | $N/A |
| Total Liabilities And Equity | $222,447 | $250,929 | $8,614 | $1,427 | $0 |